Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-12-000017

← back to feed
Filed
Nov 8, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Oct 30, 2012 111.55M sh
Operating Cash Flow Q1 2013 · Sep 30, 2012 −$1.93M
Operating Cash Flow Q1 2013 · Sep 30, 2011 −$30.74K
Cash And Equivalents Q1 2013 · Sep 30, 2012 $11.44K
Cash And Equivalents Q1 2013 · Jun 30, 2012 $2.57K
Stockholders Equity Q1 2013 · Sep 30, 2012 −$2.16M
Stockholders Equity Q1 2013 · Jun 30, 2012 −$2.08M
Total Liabilities Q1 2013 · Sep 30, 2012 $2.18M
Total Liabilities Q1 2013 · Jun 30, 2012 $2.09M
Current Assets Q1 2013 · Sep 30, 2012 $19.36K
Current Assets Q1 2013 · Jun 30, 2012 $8.84K
Net Income Q1 2013 · Sep 30, 2012 −$1.9M
Net Income Q1 2013 · Sep 30, 2011 −$27.27K
Operating Income Q1 2013 · Sep 30, 2012 −$2.19M
Operating Income Q1 2013 · Sep 30, 2011 −$27.27K